Source comparison
Best CJC-1295 No DAC Dosage for Growth Hormone Pulse: Comparison
| Protocol Type | Dose per Injection | Injection Frequency | Total Weekly Dose | Peak GH Timing | Primary Research Application | Professional Assessment ||—|—|—|—|—|—|| Standard Monotherapy | 100–200 mcg | 3× daily | 2.1–4.2 mg | 15–30 min post-injection | Bas
This comparison does not assign a generated winner or score.
- | Protocol Type | Dose per Injection | Injection Frequency | Total Weekly Dose | Peak GH Timing | Primary Research Application | Professional Assessment ||—|—|—|—|—|—|| Standard Monotherapy | 100–200 mcg | 3× daily | 2.1–4.2 mg | 15–30 min post-injection | Baseline pulsatile GH dynamics modeling | Optimal for protocols requiring preserved endogenous feedback regulation without exogenous interference || Low-Dose Stacked (with GHRP) | 50–100 mcg CJC + 100 mcg GHRP | 3× daily | 1.05–2.1 mg CJC | 15–25 min post-injection | Synergistic GH amplification studies | Produces higher peak GH with lower total CJC exposure. Preferred when minimizing peptide load matters || High-Dose Monotherapy | 200–300 mcg | 2× daily | 2.8–4.2 mg | 20–35 min post-injection | Short-term maximal pulse amplitude research | Higher per-injection GH peaks but reduced total daily pulses. Use only when 2× dosing aligns with research objectives || Pre-Sleep Only | 200–300 mcg | 1× nightly | 1.4–2.1 mg | Peak aligns with n